# Neoadjuvant FOLFIRINOX and Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer Patients

> **NCT06812728** · PHASE2 · RECRUITING · sponsor: **Menoufia University** · enrollment: 100 (estimated)

## Conditions studied

- Rectum Cancer

## Interventions

- **DRUG:** mFOLFIRINOX
- **DRUG:** mFolfox6

## Key facts

- **NCT ID:** NCT06812728
- **Lead sponsor:** Menoufia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-25
- **Primary completion:** 2027-01-25
- **Final completion:** 2027-02-25
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06812728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06812728, "Neoadjuvant FOLFIRINOX and Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer Patients". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT06812728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*